These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 31233751)
1. Zoledronic acid prevents the hepatic changes associated with high fat diet in rats; the potential role of mevalonic acid pathway in nonalcoholic steatohepatitis. Mohamed RH; Tarek M; Hamam GG; Ezzat SF Eur J Pharmacol; 2019 Sep; 858():172469. PubMed ID: 31233751 [TBL] [Abstract][Full Text] [Related]
2. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue. Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472 [TBL] [Abstract][Full Text] [Related]
3. Ameliorative effect of nicorandil on high fat diet induced non-alcoholic fatty liver disease in rats. Elshazly SM Eur J Pharmacol; 2015 Feb; 748():123-32. PubMed ID: 25542756 [TBL] [Abstract][Full Text] [Related]
4. Genistein can ameliorate hepatic inflammatory reaction in nonalcoholic steatohepatitis rats. Yin Y; Liu H; Zheng Z; Lu R; Jiang Z Biomed Pharmacother; 2019 Mar; 111():1290-1296. PubMed ID: 30841442 [TBL] [Abstract][Full Text] [Related]
5. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats. Liu J; Han L; Zhu L; Yu Y Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515 [TBL] [Abstract][Full Text] [Related]
6. [Effect of Nrf2 and related factors on the progression of nonalcoholic steatohepatitis]. Cai YQ; Zhang LZ; Wang DJ; Chen FM; Chen ZY; Zhu KY; Li JS; Yan MX Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Sep; 30(5):465-70. PubMed ID: 25571645 [TBL] [Abstract][Full Text] [Related]
7. Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat. Jiang W; Guo MH; Hai X World J Gastroenterol; 2016 Dec; 22(46):10180-10188. PubMed ID: 28028366 [TBL] [Abstract][Full Text] [Related]
8. [Preventive and therapeutic effects of compound ginkgo extract in rats with nonalcoholic steatohepatitis induced by high-fat, high-fructose diet]. Yang Q; Zhao H; Zhou AZ; Lou ZH Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):852-858. PubMed ID: 27978932 [No Abstract] [Full Text] [Related]
9. Combined treatments with metformin and phosphodiesterase inhibitors alleviate nonalcoholic fatty liver disease in high-fat diet fed rats: a comparative study. Heeba GH; El-Deen RM; Abdel-Latif RG; Khalifa MMA Can J Physiol Pharmacol; 2020 Aug; 98(8):498-505. PubMed ID: 32083947 [TBL] [Abstract][Full Text] [Related]
11. Targeting mevalonate pathway by zoledronate ameliorated pulmonary fibrosis in a rat model: Promising therapy against post-COVID-19 pulmonary fibrosis. Mohamed RH; Abdel Hay NH; Fawzy NM; Tamim YM; Doaa Karem MM; Yehia DAY; Abdel Maksoud OM; Abdelrahim DS Fundam Clin Pharmacol; 2024 Aug; 38(4):703-717. PubMed ID: 38357833 [TBL] [Abstract][Full Text] [Related]
12. [Effects of glucagon-like peptide-1 on liver oxidative stress, TNF-α and TGF-β1 in rats with non-alcoholic fatty liver disease]. Gao H; Xu L; Li D; Guang L; Deng W Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1661-4. PubMed ID: 24273273 [TBL] [Abstract][Full Text] [Related]
13. Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease. Bahabadi M; Mohammadalipour A; Karimi J; Sheikh N; Solgi G; Goudarzi F; Hashemnia M; Khodadadi I Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):233-242. PubMed ID: 28555525 [TBL] [Abstract][Full Text] [Related]
14. Raspberry ketone protects rats fed high-fat diets against nonalcoholic steatohepatitis. Wang L; Meng X; Zhang F J Med Food; 2012 May; 15(5):495-503. PubMed ID: 22551412 [TBL] [Abstract][Full Text] [Related]
15. Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils. Ying HZ; Liu YH; Yu B; Wang ZY; Zang JN; Yu CH Food Chem Toxicol; 2013 Feb; 52():53-60. PubMed ID: 23123425 [TBL] [Abstract][Full Text] [Related]
16. Combination of Hypertension Along with a High Fat and Cholesterol Diet Induces Severe Hepatic Inflammation in Rats via a Signaling Network Comprising NF-κB, MAPK, and Nrf2 Pathways. Yuan Y; Naito H; Jia X; Kitamori K; Nakajima T Nutrients; 2017 Sep; 9(9):. PubMed ID: 28906458 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic Effect of Gypenosides on Nonalcoholic Steatohepatitis via Regulating Hepatic Lipogenesis and Fatty Acid Oxidation. Li H; Ying H; Hu A; Hu Y; Li D Biol Pharm Bull; 2017; 40(5):650-657. PubMed ID: 28458350 [TBL] [Abstract][Full Text] [Related]
18. Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression. Abd El-Haleim EA; Bahgat AK; Saleh S World J Gastroenterol; 2016 Mar; 22(10):2931-48. PubMed ID: 26973390 [TBL] [Abstract][Full Text] [Related]
19. [Effect of apigenin on protein expressions of PPARs in liver tissues of rats with nonalcoholic steatohepatitis]. Shi T; Zhuang R; Zhou H; Wang F; Shao Y; Cai Z Zhonghua Gan Zang Bing Za Zhi; 2015 Feb; 23(2):124-9. PubMed ID: 25880979 [TBL] [Abstract][Full Text] [Related]
20. The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α. Ren T; Zhu J; Zhu L; Cheng M Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]